(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

FORMULAÇÃO AQUOSA DE ANTICORPO ANTI-PD-L1

Em ExigênciaInvention PatentPCT · EP2018055404

Application data

Number

112019018401

Type

Invention Patent

Filing

03/06/2018

Publication

04/07/2020

PCT

EP2018055404

Progress at the INPI

Office action pending
  1. Filing03/06/18
  2. Publication04/07/20
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The INPI issued a technical office action on this application. If it is not answered in time, the application is abandoned (art. 36 of the Brazilian IP Act).

Deadline to answer the office action:11/09/2026(76 days left)

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 08/11/2026. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

MERCK PATENT GMBH

DE

PFIZER, INC.

US

See this company's full portfolio

Inventors

A. R. (pessoa física)

IT

G. R. (pessoa física)

IT

M. S. (pessoa física)

IT

S. F. (pessoa física)

IT

Technical data

IPC Classification

Priority claims

EP

17159354.4 · 03/06/2017

Abstract

A presente invenção refere-se a uma nova formulação de anticorpo anti-PD-L1. Em particular, a invenção refere-se a uma formulação farmacêutica aquosa do anticorpo anti-TP-L Avelumab.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Exigência - art. 36 da LPI

#6.1

08/11/2026

RPI 2901

Exigência - art. 36 da LPI

#6.1

06/09/2026

RPI 2892

Parecer de pré-exame

#6.23

07/08/2025

RPI 2844

Adição na publicação

#15.35

10/19/2021

RPI 2650

Notificação de entrada na fase nacional - PCT

#1.3

04/07/2020

RPI 2570

Alteração de dados cadastrais

#1.1

09/17/2019

RPI 2541

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.